|
Delayed
Hong Kong S.E.
07:15:42 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 11.44 HKD | -3.46% |
|
+2.50% | -4.18% |
| 09-30 | Major drugmakers turn to China for licensing deals | RE |
| 09-04 | Simcere Pharma's Yingmule Gets China Marketing Approval for RSV Prevention | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Generic Pharmaceuticals | -3.46% | +2.50% | -4.18% | -13.24% | +71.96% | 3.88B |  | | |
- Stock Market
- Stocks
- 2096 Stock
- Charts Simcere Pharmaceutical Group Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
